FDA Adverse Event Death Summary report: N

XIENCE EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 11324733 · Received February 12, 2021

Report

Report Number
2024168-2021-01175
Event Type
Death
Date Received
February 12, 2021
Date of Event
March 29, 2017
Report Date
February 12, 2021
Manufacturer
ABBOTT VASCULAR
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DATE OF DEATH, EVENT, TESTS, THERAPY, AND IMPLANT: DATE IS ESTIMATED. UNIQUE DEVICE IDENTIFIER (UDI#): IN THE ABSENCE OF A REPORTED PART NUMBER, THE UDI CANNOT BE CALCULATED. THE DEVICE WAS NOT RETURNED FOR EVALUATION. A REVIEW OF THE LOT HISTORY RECORD COULD NOT BE CONDUCTED BECAUSE THE PART AND LOT NUMBERS WERE NOT PROVIDED. THE REPORTED PATIENT EFFECT OF DEATH IS LISTED IN THE XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEMS INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT OF CORONARY PROCEDURES. A CONCLUSIVE CAUSE FOR THE REPORTED DEATH AND THE RELATIONSHIP TO THE PRODUCT, IF ANY, CANNOT BE DETERMINED. THERE IS NO INDICATION OF A PRODUCT QUALITY ISSUE WITH RESPECT TO MANUFACTURE, DESIGN OR LABELING. THE ADDITIONAL ADVERSE PATIENT EFFECTS REFERENCED ARE BEING FILED UNDER A SEPARATE MEDWATCH REPORT #. ARTICLE TITLED GEOGRAPHICAL DIFFERENCE OF THE INTERACTION OF SEX WITH TREATMENT STRATEGY IN PATIENTS WITH MULTIVESSEL DISEASE AND LEFT MAIN DISEASE."

Description of Event or Problem · 1

IT WAS REPORTED THROUGH A RESEARCH ARTICLE IDENTIFYING XIENCE DRUG-ELUTING STENTS THAT MAY BE RELATED TO THE FOLLOWING: MYOCARDIAL INFARCTION, STROKE, REVASCULARIZATION, AND DEATH. DETAILS ARE LISTED IN THE ARTICLE, TITLED GEOGRAPHICAL DIFFERENCE OF THE INTERACTION OF SEX WITH TREATMENT STRATEGY IN PATIENTS WITH MULTIVESSEL DISEASE AND LEFT MAIN DISEASE."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
217557 XIENCE EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT DELIVERY SYSTEM NIQ ABBOTT VASCULAR

Patients

Seq Age Sex Outcome Treatment
1 Death